Jefferies Diagnoses Dr Pepper With A Buy Rating By: Benzinga via Benzinga March 03, 2017 at 15:30 PM EST Bolstered by a U.S.-centric strategy, stability in its base business and the continued trending of its Bai brand, Dr Pepper Snapple ... Read More >> Related Stocks: Dr. Pepper Snapple Group